{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T16:05:21Z","timestamp":1781107521128,"version":"3.54.1"},"reference-count":0,"publisher":"Canadian Society of Healthcare-Systems Pharmacy","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can J Hosp Pharm"],"abstract":"<jats:p>Background: International pharmacy graduates (IPGs) are underrepresented in Canadian hospitals. It has been speculated that structural factors, particularly limited access to residency programs, may contribute to IPGs\u2019 disproportionate streaming toward community pharmacy practice.\nObjectives: To review the criteria of accredited hospital pharmacy residency programs in Canada to determine whether IPGs are eligible to apply, to examine the extent of IPGs\u2019 participation and success in securing hospital pharmacy residency positions, and to determine the factors that influence success in the matching process.\nMethods: A policy scan of accredited residency programs that participate in the Canadian Pharmacy Residency Board matching program was conducted in September 2023. In addition, a descriptive cross-sectional study was performed using available application data from the Pharmacy Residency Application and Matching Service in Canada for the 2022\/23 matching cycle (January 2023 match).\nResults: Of the 40 participating residency programs, 7 (17.5%) required graduation from a North American\u2013accredited institution, whereas the others accepted candidates with eligibility for licensure in any Canadian province. Only one program explicitly mentioned and encouraged IPGs to apply. In the matching data, only 19 (6.2%) of 308 applicants were IPGs, of whom 3 (16%) were successfully matched to a program, whereas 131 (45.3%) of 289 domestic graduates were matched. There was a significant association between country of graduation and residency matching, with lower odds of matching for IPGs (adjusted odds ratio 0.230, 95% confidence interval 0.063\u20130.845).\nConclusion: These results show that IPGs are substantially underrepresented in the residency application and matching processes and provides insights into potential systemic barriers that need to be addressed by policy-makers and stakeholders.\nKeywords: international pharmacy graduates, hospital practice, institutional setting, integration, residency training, matching, equity, diversity, inclusion\nR\u00c9SUM\u00c9\nContexte : Les dipl\u00f4m\u00e9s en pharmacie form\u00e9s \u00e0 l\u2019\u00e9tranger (DPE) sont sous-repr\u00e9sent\u00e9s dans les h\u00f4pitaux canadiens. On a \u00e9mis l\u2019hypoth\u00e8se que des facteurs structurels, notamment un acc\u00e8s limit\u00e9 aux programmes de r\u00e9sidence, pourraient amener les DPE \u00e0 s\u2019orienter vers la pratique en pharmacie communautaire de fa\u00e7on disproportionn\u00e9e.\nObjectifs : Examiner les crit\u00e8res des programmes de r\u00e9sidence en pharmacie d\u2019h\u00f4pital accr\u00e9dit\u00e9s au Canada, en mettant l\u2019accent sur l\u2019admissibilit\u00e9 des DPE \u00e0 postuler; \u00e9tudier l\u2019\u00e9tendue de leur participation et leur r\u00e9ussite \u00e0 obtenir des postes de r\u00e9sident en pharmacie d\u2019h\u00f4pital; et d\u00e9finir les facteurs qui influencent la r\u00e9ussite dans le processus de jumelage.\nM\u00e9thodologie : Une analyse des politiques des programmes de r\u00e9sidence accr\u00e9dit\u00e9s participant au programme national de jumelage du Conseil canadien de r\u00e9sidence en pharmacie a \u00e9t\u00e9 r\u00e9alis\u00e9e en septembre 2023. De plus, une \u00e9tude transversale descriptive a \u00e9t\u00e9 men\u00e9e en utilisant les donn\u00e9es de candidature disponibles du Service de demande et de jumelage des r\u00e9sidences en pharmacie du Canada pour le cycle de jumelage 2022\/23 (jumelage de janvier 2023).\nR\u00e9sultats : Sur les 40 programmes participants, 7 (17,5 %) exigeaient un dipl\u00f4me d\u2019une institution accr\u00e9dit\u00e9e en Am\u00e9rique du Nord, tandis que les autres acceptaient des candidats admissibles \u00e0 la licence dans n\u2019importe quelle province canadienne. Seul un programme mentionnait les DPE et les encourageait explicitement \u00e0 soumettre leur candidature. Dans les donn\u00e9es de jumelage, seulement 19 (6,2 %) des 308 candidats \u00e9taient des DPE, dont 3 (16 %) ont \u00e9t\u00e9 jumel\u00e9s dans un programme, tandis que 131 (45,3 %) des 289 dipl\u00f4m\u00e9s nationaux ont \u00e9t\u00e9 jumel\u00e9s. Une forte association a \u00e9t\u00e9 observ\u00e9e entre le pays d\u2019obtention du dipl\u00f4me et le jumelage dans un programme de r\u00e9sidence, et les DPE avaient moins de chances d\u2019\u00eatre s\u00e9lectionn\u00e9s (rapport de cotes ajust\u00e9 de 0,230, intervalle de confiance \u00e0 95 % de 0,063 \u00e0 0,845).\nConclusion : Ces r\u00e9sultats montrent que les DPE sont nettement sous-repr\u00e9sent\u00e9s dans les processus de candidature et de jumelage pour les r\u00e9sidences; ils donnent des informations sur les obstacles syst\u00e9miques potentiels qui doivent \u00eatre abord\u00e9s par les d\u00e9cideurs et les parties prenantes.\nMots-cl\u00e9s : dipl\u00f4m\u00e9s en pharmacie form\u00e9s \u00e0 l\u2019\u00e9tranger, pratique hospitali\u00e8re, environnement institutionnel, int\u00e9gration, formation \u00e0 la r\u00e9sidence, jumelage, \u00e9quit\u00e9, diversit\u00e9, inclusion<\/jats:p>","DOI":"10.4212\/cjhp.3882","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:53:02Z","timestamp":1781106782000},"source":"Crossref","is-referenced-by-count":0,"title":["Eligibility, Participation, and Matching Outcomes of International Pharmacy Graduates in Accredited Pharmacy Residency Programs in Canada: A Policy Scan and Cross-Sectional Analysis"],"prefix":"10.4212","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2426-9528","authenticated-orcid":false,"given":"Mhd Wasem","family":"Alsabbagh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7436-9423","authenticated-orcid":false,"given":"Deep","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4796-0282","authenticated-orcid":false,"given":"Tim","family":"Mickleborough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2732","published-online":{"date-parts":[[2026,6,10]]},"container-title":["Canadian Journal of Hospital Pharmacy"],"original-title":[],"link":[{"URL":"https:\/\/www.cjhp-online.ca\/index.php\/cjhp\/article\/download\/3882\/5897","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cjhp-online.ca\/index.php\/cjhp\/article\/download\/3882\/5900","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cjhp-online.ca\/index.php\/cjhp\/article\/download\/3882\/5897","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:53:03Z","timestamp":1781106783000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cjhp-online.ca\/index.php\/cjhp\/article\/view\/3882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":0,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6,10]]}},"URL":"https:\/\/doi.org\/10.4212\/cjhp.3882","relation":{},"ISSN":["1920-2903","0008-4123"],"issn-type":[{"value":"1920-2903","type":"electronic"},{"value":"0008-4123","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"article-number":"e3882"}}